Literature DB >> 28114273

The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity.

Kenneth D Bromberg1, Taylor R H Mitchell2, Anup K Upadhyay1, Clarissa G Jakob1, Manisha A Jhala1, Kenneth M Comess1, Loren M Lasko1, Conglei Li3, Creighton T Tuzon4, Yujia Dai1, Fengling Li2, Mohammad S Eram2, Alexander Nuber5, Niru B Soni1, Vlasios Manaves1, Mikkel A Algire1, Ramzi F Sweis1, Maricel Torrent1, Gunnar Schotta5, Chaohong Sun1, Michael R Michaelides1, Alex R Shoemaker1, Cheryl H Arrowsmith2, Peter J Brown2, Vijayaratnam Santhakumar2, Alberto Martin3, Judd C Rice4, Gary G Chiang1,6, Masoud Vedadi2,7, Dalia Barsyte-Lovejoy2, William N Pappano1.   

Abstract

Protein lysine methyltransferases (PKMTs) regulate diverse physiological processes including transcription and the maintenance of genomic integrity. Genetic studies suggest that the PKMTs SUV420H1 and SUV420H2 facilitate proficient nonhomologous end-joining (NHEJ)-directed DNA repair by catalyzing the di- and trimethylation (me2 and me3, respectively) of lysine 20 on histone 4 (H4K20). Here we report the identification of A-196, a potent and selective inhibitor of SUV420H1 and SUV420H2. Biochemical and co-crystallization analyses demonstrate that A-196 is a substrate-competitive inhibitor of both SUV4-20 enzymes. In cells, A-196 induced a global decrease in H4K20me2 and H4K20me3 and a concomitant increase in H4K20me1. A-196 inhibited 53BP1 foci formation upon ionizing radiation and reduced NHEJ-mediated DNA-break repair but did not affect homology-directed repair. These results demonstrate the role of SUV4-20 enzymatic activity in H4K20 methylation and DNA repair. A-196 represents a first-in-class chemical probe of SUV4-20 to investigate the role of histone methyltransferases in genomic integrity.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28114273     DOI: 10.1038/nchembio.2282

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  44 in total

1.  Crystal structures of the human histone H4K20 methyltransferases SUV420H1 and SUV420H2.

Authors:  Hong Wu; Alena Siarheyeva; Hong Zeng; Robert Lam; Aiping Dong; Xian-Hui Wu; Yanjun Li; Matthieu Schapira; Masoud Vedadi; Jinrong Min
Journal:  FEBS Lett       Date:  2013-11-29       Impact factor: 4.124

Review 2.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

3.  The SAGA Deubiquitination Module Promotes DNA Repair and Class Switch Recombination through ATM and DNAPK-Mediated γH2AX Formation.

Authors:  Shaliny Ramachandran; Dania Haddad; Conglei Li; Michael X Le; Alexanda K Ling; Clare C So; Rajeev M Nepal; Jennifer L Gommerman; Kefei Yu; Troy Ketela; Jason Moffat; Alberto Martin
Journal:  Cell Rep       Date:  2016-05-05       Impact factor: 9.423

4.  The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells.

Authors:  Mathieu Tardat; Julien Brustel; Olivier Kirsh; Christine Lefevbre; Mary Callanan; Claude Sardet; Eric Julien
Journal:  Nat Cell Biol       Date:  2010-10-17       Impact factor: 28.824

Review 5.  Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.

Authors:  Christoph Plass; Stefan M Pfister; Anders M Lindroth; Olga Bogatyrova; Rainer Claus; Peter Lichter
Journal:  Nat Rev Genet       Date:  2013-10-09       Impact factor: 53.242

6.  I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks.

Authors:  Amanda Gunn; Jeremy M Stark
Journal:  Methods Mol Biol       Date:  2012

7.  Suv4-20h abrogation enhances telomere elongation during reprogramming and confers a higher tumorigenic potential to iPS cells.

Authors:  Rosa M Marión; Gunnar Schotta; Sagrario Ortega; Maria A Blasco
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

8.  LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.

Authors:  Hannah Nguyen; Abdellah Allali-Hassani; Stephen Antonysamy; Shawn Chang; Lisa Hong Chen; Carmen Curtis; Spencer Emtage; Li Fan; Tarun Gheyi; Fengling Li; Shichong Liu; Joseph R Martin; David Mendel; Jonathan B Olsen; Laura Pelletier; Tatiana Shatseva; Song Wu; Feiyu Fred Zhang; Cheryl H Arrowsmith; Peter J Brown; Robert M Campbell; Benjamin A Garcia; Dalia Barsyte-Lovejoy; Mary Mader; Masoud Vedadi
Journal:  J Biol Chem       Date:  2015-03-30       Impact factor: 5.157

9.  Impact of histone H4 lysine 20 methylation on 53BP1 responses to chromosomal double strand breaks.

Authors:  Andrea J Hartlerode; Yinghua Guan; Anbazhagan Rajendran; Kiyoe Ura; Gunnar Schotta; Anyong Xie; Jagesh V Shah; Ralph Scully
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  39 in total

Review 1.  Inhibitors of Protein Methyltransferases and Demethylases.

Authors:  H Ümit Kaniskan; Michael L Martini; Jian Jin
Journal:  Chem Rev       Date:  2017-03-24       Impact factor: 60.622

Review 2.  Recent progress in developing selective inhibitors of protein methyltransferases.

Authors:  H Ümit Kaniskan; Jian Jin
Journal:  Curr Opin Chem Biol       Date:  2017-06-26       Impact factor: 8.822

3.  Multiplexed Imaging of Posttranslational Modifications of Endogenous Proteins in Live Cells.

Authors:  Yuko Sato; Hiroshi Kimura
Journal:  Methods Mol Biol       Date:  2021

4.  Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).

Authors:  Nicolas Babault; Abdellah Allali-Hassani; Fengling Li; Jie Fan; Alex Yue; Kevin Ju; Feng Liu; Masoud Vedadi; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2018-01-31       Impact factor: 7.446

5.  Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Authors:  Loren M Lasko; Clarissa G Jakob; Rohinton P Edalji; Wei Qiu; Debra Montgomery; Enrico L Digiammarino; T Matt Hansen; Roberto M Risi; Robin Frey; Vlasios Manaves; Bailin Shaw; Mikkel Algire; Paul Hessler; Lloyd T Lam; Tamar Uziel; Emily Faivre; Debra Ferguson; Fritz G Buchanan; Ruth L Martin; Maricel Torrent; Gary G Chiang; Kannan Karukurichi; J William Langston; Brian T Weinert; Chunaram Choudhary; Peter de Vries; John H Van Drie; David McElligott; Ed Kesicki; Ronen Marmorstein; Chaohong Sun; Philip A Cole; Saul H Rosenberg; Michael R Michaelides; Albert Lai; Kenneth D Bromberg
Journal:  Nature       Date:  2017-09-27       Impact factor: 49.962

Review 6.  Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease.

Authors:  Kamakoti P Bhat; H Ümit Kaniskan; Jian Jin; Or Gozani
Journal:  Nat Rev Drug Discov       Date:  2021-01-19       Impact factor: 84.694

Review 7.  Lysine methyltransferase inhibitors: where we are now.

Authors:  Alessandra Feoli; Monica Viviano; Alessandra Cipriano; Ciro Milite; Sabrina Castellano; Gianluca Sbardella
Journal:  RSC Chem Biol       Date:  2021-12-13

8.  Proteomic approaches for cancer epigenetics research.

Authors:  Dylan M Marchione; Benjamin A Garcia; John Wojcik
Journal:  Expert Rev Proteomics       Date:  2018-11-27       Impact factor: 3.940

9.  KMT5c modulates adipocyte thermogenesis by regulating Trp53 expression.

Authors:  Qingwen Zhao; Zhe Zhang; Weiqiong Rong; Weiwei Jin; Linyu Yan; Wenfang Jin; Yingjiang Xu; Xuan Cui; Qi-Qun Tang; Dongning Pan
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-24       Impact factor: 11.205

10.  A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion.

Authors:  Xiao-Chuan Cai; Tuo Zhang; Eui-Jun Kim; Ming Jiang; Ke Wang; Junyi Wang; Shi Chen; Nawei Zhang; Hong Wu; Fengling Li; Carlo C Dela Seña; Hong Zeng; Victor Vivcharuk; Xiang Niu; Weihong Zheng; Jonghan P Lee; Yuling Chen; Dalia Barsyte; Magda Szewczyk; Taraneh Hajian; Glorymar Ibáñez; Aiping Dong; Ludmila Dombrovski; Zhenyu Zhang; Haiteng Deng; Jinrong Min; Cheryl H Arrowsmith; Linas Mazutis; Lei Shi; Masoud Vedadi; Peter J Brown; Jenny Xiang; Li-Xuan Qin; Wei Xu; Minkui Luo
Journal:  Elife       Date:  2019-10-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.